Comprehensive clinical analysis indicates that patients carrying PTCHD1 deletions have a variable non-syndromic neurodevelopmental disorder with symptoms including attention deficit, hyperactivity, sleep abnormality, hypotonia, and learning disability20. Here, PTCHD1 is linked to neurodevelopmental disorder.